Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Olmesartan Medoxomil 40 mg tablets relative to OLMETEC 40 mg in healthy Thai volunteers under fasting conditions
TCTR20240512002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of olmesartan in hypertension (HTN) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20240512002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240512002.